The DOI matches its Crossref record; 216 of the 216 references it cites were found in a registry or an index.
Mechanisms for Modulating Anoikis Resistance in Cancer and the Relevance of Metabolic Reprogramming
Open accessAbstract
The attachment of cells to the extracellular matrix (ECM) is the hallmark of structure–function stability and well-being. ECM detachment in localized tumors precedes abnormal dissemination of tumor cells culminating in metastasis. Programmed cell death (PCD) is activated during tumorigenesis to clear off ECM-detached cells through “anoikis.” However, cancer cells develop several mechanisms for abrogating anoikis, thus promoting their invasiveness and metastasis. Specific factors, such as growth proteins, pH, transcriptional signaling pathways, and oxidative stress, have been reported as drivers of anoikis resistance, thus enhancing cancer proliferation and metastasis. Recent studies highlighted the key contributions of metabolic pathways, enabling the cells to bypass anoikis. Therefore, understanding the mechanisms driving anoikis resistance could help to counteract tumor progression and prevent metastasis. This review elucidates the dynamics employed by cancer cells to impede anoikis, thus promoting proliferation, invasion, and metastasis. In addition, the authors have discussed other metabolic intermediates (especially amino acids and nucleotides) that are less explored, which could be crucial for anoikis resistance and metastasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–216 of 216
RhoGEFs in Cell Motility: Novel Links Between Rgnef and Focal Adhesion Kinase
Miller, N. L. G., Kleinschmidt, E. G., & Schlaepfer, D. D. (2014) · Current Molecular Medicine · doi:10.2174/1566524014666140128110339 · Cited by 35
Žúbor, P., Daňková, Z., Kolková, Z., Holubeková, V., Braný, D., Meršaková, S., Samec, M., Líšková, A., Koklesová, L., Kubatka, P., et al. (2020) · Cancers · doi:10.3390/cancers12051292 · Cited by 34
Treatment Algorithms for Patients with Metastatic Non-Small Cell, Non-Squamous Lung Cancer
Melosky, B. L. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00256 · Cited by 33
Zhang, P., Xing, Z., Li, X., Song, Y., Zhao, J., Xiao, Y., & Xing, Y. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3356 · Cited by 32
Li, S., Mao, Y., Zhou, T., Luo, C., Xie, J., Qi, W., Yang, Z., Ma, J., Gao, G., & Xia, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.8717 · Cited by 31
Acquisition of Anoikis Resistance Up-Regulates Syndecan-4 Expression in Endothelial Cells
Carneiro, B. R., Filho, P. C. A. P., Mesquita, A. P. D. S., da Silva, D. S., Pinhal, M. A. D. S., Nader, H. B., & Lopes, C. C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0116001 · Cited by 28
The anticancer phytochemical rocaglamide inhibits Rho GTPase activity and cancer cell migration
Becker, M. S., Müller, P. M., Bajorat, J., Schroeder, A., Giaisi, M., Amin, E., Ahmadian, M. R., Rocks, O., Köhler, R., Krammer, P. H., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10188 · Cited by 28
Current Treatment Algorithms for Patients with Metastatic Non-Small Cell, Non-Squamous Lung Cancer
Melosky, B. L. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00038 · Cited by 21
Cao, L., Zhang, Z., Han, L., Du, J., Liang, X., Liu, Y., & Sun, W. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.1952 · Cited by 19
Hu, B., Zhang, T., An, H., Zheng, J., Xia, Y., & Huang, X. (2018) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-018-2083-2 · Cited by 16
Maurer, G. D., Brucker, D. P., & Steinbach, J. P. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.05.115 · Cited by 16
Inhibition of Rho-Associated Kinase Suppresses Medulloblastoma Growth
Dyberg, C. H., Andonova, T., Olsen, T. K., Brodin, B. A., Kool, M., Kogner, P., Johnsen, J. I., & Wickström, M. (2019) · Cancers · doi:10.3390/cancers12010073 · Cited by 16
Hsu, C.-L., Chung, F.-H., Chen, C., Hsu, T.-T., Liu, S., Chung, D.-S., Hsu, Y.-F., Chen, C., Ma, N. J.-L., & Lee, H.-C. (2016) · Scientific Reports · doi:10.1038/srep32523 · Cited by 14
Zhao, G., Zhang, Q., Cao, Y., Wang, Y., Lv, Y., Zhang, Z., Zhang, Y., Tan, Q., Chang, Y., Quan, Z., et al. (2019) · PubMed · Cited by 14
Tseng, T., Uen, W.-C., Tseng, J., & Lee, S.-C. (2017) · Oncotarget · doi:10.18632/oncotarget.18616 · Cited by 11
Zhang, J., Huang, J., Chen, Y., Yuan, F., Zhang, H., Yan, F. H., Wang, M., Wang, G., Su, M., Lu, G.-M., et al. (2015) · Scientific Reports · doi:10.1038/srep15309 · Cited by 11
Cited by
Navigating the complexities of cell death: Insights into accidental and programmed cell death
Lotfi, M.-S., & Rassouli, F. B. (2024) · Tissue and Cell · doi:10.1016/j.tice.2024.102586 · Cited by 15
Metadata
- Authors
- Adeshakin, F. O., Adeshakin, A. O., Afolabi, L. O., Yan, D., Zhang, G., & Wan, X.
- Venue
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Published
- 2021-03-29
- Volume
- 11
- Pages
- 626577-626577
- ISSN
- 2234-943X (ISSN-L)
- OpenAlex
- W3144812939
- Cited by
- 271
- References
- 216
- FWCI
- 13.15
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.